Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the best stocks to buy under $20. On September 19, Syndax Pharmaceuticals ...

City of Hope® Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, ...

The selection of patients for allo-HSCT and the best approach to bridging patients to transplantation is continuously ...

Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...

Spontaneous regression is most commonly reported in neuroblastoma and leukemia. Case series link infection, transfusion, and ...

Courtney Luyando of Seymour lost her son Greyson, 12, to leukemia in May and decided to run her first marathon in Hartford ...

A Bay Area biotech company is on the cusp of a potential breakthrough in blood cancer treatment, with regulators set to make ...

PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2025 AND KEY EVENTS DURING THE PERIOD Financial and corporate situation Operating deficit reduced by 24% compared to the ...

The 40-year-old was given the shock news she had acute myeloid leukaemia (AML) and is now urging others to not ignore the ...

Former journalist Loriana Hernández-Aldama speaks on journey through breast cancer, leukemia. She is sending an important ...

Ohio State researchers recently solved a critical mystery explaining why some cancer immunotherapies fail[1], while a ...